Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Bradfield Investments’ Q1 2019 Investor Letter

Bradfield Investments recently shared its Q1 2019 Investor Letter, a copy of which you can download below. The fund reported YTD return of 10.19% underperforming the S&P 500 which generated a return of 17.75% in the same period.

Dear Partners,

Year to date our portfolio has returned 10.19%, and our annual return for the year ending 2018 was 15.39%. Comparatively, the S&P500 has returned 17.75% YTD, but returned a whooping-4.85 for 2018.

We added to our positions in Reckitt Benckiser and Summerset, and maintained our position in Republic Services. We also added Apple to our portfolio when it dipped to$140 per share,a substantial discount to its intrinsic value.”

You can download a copy of Bradfield Investments’ Q1 2019 Investor Letter here:

Bradfield Investments q1 2019

You can also see the list of our 2019 Q1 investor letters and download them on this page.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.